Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Tango Therapeutics, Inc. (TNGX)

$22.20 -4.91% NASDAQ: TNGX · 15-min delayed
  • BOSTON, Massachusetts
  • Public · NASDAQ: TNGX
  • 137 employees
$4.3BMarket cap
$62.4MRevenue · FY2025
-$101.6MNet income
137Employees
TNGXNASDAQ
2021IPO

About Tango Therapeutics, Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$62.4M
Net income
-$101.6M
Total assets
$398.7M
Market cap
$4.3B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: TNGX
$22.20 -4.91%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$6.91 $32.90

52-week range

Market cap
$4.3B
Shares outstanding
195.3M
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Aug 11, 2021

Tango Therapeutics, Inc. (TNGX) Stock Price

  • Reported a net loss of $101.6M in FY2025.
  • Trading 33% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Tango Therapeutics, Inc..

Write a review
Newsroom

News about Tango Therapeutics, Inc.

News & sentiment via Polygon.io

FAQ

Tango Therapeutics, Inc.: frequently asked questions

Is Tango Therapeutics, Inc. an American company?

Tango Therapeutics, Inc. is a US-based company headquartered in Boston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Tango Therapeutics, Inc. headquartered?

Tango Therapeutics, Inc. is headquartered in Boston, Massachusetts, United States.

Is Tango Therapeutics, Inc. publicly traded?

Yes — Tango Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol TNGX on the NASDAQ.

What does Tango Therapeutics, Inc. do?

Tango Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →